特异性T细胞-话题@MedSci

#特异性T细胞#

20篇内容 | 715人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1654977, encodeId=035f16549e7a1, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应, objectType=article, longId=219890, objectId=ae67219890fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae67219890fc, replyNumber=0, likeNumber=42, createdTime=2022-06-14, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae67219890fc, moduleTitle=ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae67219890fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654976, encodeId=da8f16549e68a, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=J Infect Dis:新冠病毒特异性T细胞在感染后12个月后仍然具有较高的表达, objectType=article, longId=219187, objectId=9c6f21918ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c6f21918ed6, replyNumber=0, likeNumber=32, createdTime=2022-06-26, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c6f21918ed6, moduleTitle=J Infect Dis:新冠病毒特异性T细胞在感染后12个月后仍然具有较高的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c6f21918ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654975, encodeId=5d3516549e528, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性, objectType=article, longId=205939, objectId=eb6620593938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb6620593938, replyNumber=0, likeNumber=40, createdTime=2021-08-27, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb6620593938, moduleTitle=Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb6620593938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654969, encodeId=906a1654969e9, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学, objectType=article, longId=196682, objectId=82e919668267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82e919668267, replyNumber=0, likeNumber=33, createdTime=2020-12-29, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82e919668267, moduleTitle=Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82e919668267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654971, encodeId=959916549e1d8, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Clin Cancer Res：CMV特异性T细胞治疗胶质母细胞瘤, objectType=article, longId=198656, objectId=0c7a19865694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c7a19865694, replyNumber=0, likeNumber=27, createdTime=2021-02-20, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c7a19865694, moduleTitle=Clin Cancer Res：CMV特异性T细胞治疗胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c7a19865694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654974, encodeId=be7316549e4cd, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Blood：SARS-CoV-2特异性T细胞可快速扩增以用于临床治疗, objectType=article, longId=203194, objectId=5e9220319480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e9220319480, replyNumber=0, likeNumber=35, createdTime=2021-02-01, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e9220319480, moduleTitle=Blood：SARS-CoV-2特异性T细胞可快速扩增以用于临床治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e9220319480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654973, encodeId=ee3b16549e373, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Nat Med：抗HIV-1抗体联合治疗与病毒特异性T细胞免疫力增强相关, objectType=article, longId=201414, objectId=04e72014140f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04e72014140f, replyNumber=0, likeNumber=32, createdTime=2021-05-19, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04e72014140f, moduleTitle=Nat Med：抗HIV-1抗体联合治疗与病毒特异性T细胞免疫力增强相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04e72014140f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654972, encodeId=e49716549e2c0, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=EBV特异性T细胞免疫疗法ATA188治疗多发性硬化症：所有剂量组均取得积极结果, objectType=article, longId=200586, objectId=adbc20058698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adbc20058698, replyNumber=0, likeNumber=51, createdTime=2020-12-09, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adbc20058698, moduleTitle=EBV特异性T细胞免疫疗法ATA188治疗多发性硬化症：所有剂量组均取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adbc20058698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654970, encodeId=e91c16549e0bc, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关, objectType=article, longId=198103, objectId=007f198103cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007f198103cb, replyNumber=0, likeNumber=33, createdTime=2020-08-19, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007f198103cb, moduleTitle=Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=007f198103cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654968, encodeId=2b821654968a6, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Blood：在骨髓移植后，EBV/LMP特异性T细胞可有效维持EBV相关淋巴瘤的缓解, objectType=article, longId=149907, objectId=504f14990ee3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=504f14990ee3, replyNumber=0, likeNumber=36, createdTime=2019-04-07, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=504f14990ee3, moduleTitle=Blood：在骨髓移植后，EBV/LMP特异性T细胞可有效维持EBV相关淋巴瘤的缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=504f14990ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654966, encodeId=9d321654966a0, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=CLIN CANCER RES：瘤内HPV16特异性T细胞可以改善HPV16导致的口咽癌预后, objectType=article, longId=130636, objectId=6a52130636c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a52130636c4, replyNumber=0, likeNumber=29, createdTime=2019-01-15, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a52130636c4, moduleTitle=CLIN CANCER RES：瘤内HPV16特异性T细胞可以改善HPV16导致的口咽癌预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a52130636c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654965, encodeId=c7901654965f6, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, objectType=article, longId=128450, objectId=3188128450b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3188128450b5, replyNumber=0, likeNumber=40, createdTime=2018-05-03, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3188128450b5, moduleTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3188128450b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654967, encodeId=c7b5165496e8f, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！, objectType=article, longId=144636, objectId=797e14463657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=797e14463657, replyNumber=0, likeNumber=27, createdTime=2018-09-27, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=797e14463657, moduleTitle=Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=797e14463657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654963, encodeId=b3dc165496385, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染, objectType=article, longId=107560, objectId=d77410e56005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77410e56005, replyNumber=0, likeNumber=27, createdTime=2018-06-28, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77410e56005, moduleTitle=J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77410e56005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654964, encodeId=a56716549649e, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=JCO：病毒特异性T细胞可以抗病毒？, objectType=article, longId=108086, objectId=5a811080860f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a811080860f, replyNumber=0, likeNumber=20, createdTime=2018-03-31, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a811080860f, moduleTitle=JCO：病毒特异性T细胞可以抗病毒？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a811080860f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654962, encodeId=fb6b1654962db, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=J immunol：CD200R信号调节肿瘤特异性T细胞免疫反应, objectType=article, longId=72370, objectId=f76fe2370ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f76fe2370ff, replyNumber=0, likeNumber=33, createdTime=2016-07-14, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f76fe2370ff, moduleTitle=J immunol：CD200R信号调节肿瘤特异性T细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f76fe2370ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654961, encodeId=d894165496125, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Clin Trans Immunol：PD-1抗体能够激活抗原特异性T细胞免疫反应, objectType=article, longId=69492, objectId=2aea6949284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2aea6949284, replyNumber=0, likeNumber=31, createdTime=2016-12-27, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2aea6949284, moduleTitle=Clin Trans Immunol：PD-1抗体能够激活抗原特异性T细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aea6949284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654960, encodeId=6d4b165496055, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Nature ：同种异体IgG联合DC能强烈激活肿瘤特异性T细胞, objectType=article, longId=50430, objectId=1649504301b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1649504301b, replyNumber=0, likeNumber=37, createdTime=2015-07-01, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1649504301b, moduleTitle=Nature ：同种异体IgG联合DC能强烈激活肿瘤特异性T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1649504301b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654959, encodeId=2e1f1654959a6, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=Science：ILC -III介导微生物特异性T细胞“阴性选择”, objectType=article, longId=49898, objectId=0f704989844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f704989844, replyNumber=0, likeNumber=40, createdTime=2015-07-27, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f704989844, moduleTitle=Science：ILC -III介导微生物特异性T细胞“阴性选择”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f704989844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654958, encodeId=fb07165495856, content=<a href='/topic/show?id=35456e943af' target=_blank style='color:#2F92EE;'>#特异性T细胞#</a>, objectTitle=CELL STEM CELL：日培育出肿瘤抗原特异性T细胞, objectType=article, longId=14160, objectId=a8d0141605e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d0141605e, replyNumber=0, likeNumber=32, createdTime=2013-07-12, rootId=0, userName=zhucaizhong7774, userId=237424588948, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d0141605e, moduleTitle=CELL STEM CELL：日培育出肿瘤抗原特异性T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d0141605e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性T细胞

2020-05-29

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

ARD：单细胞转录组分析可识别系统性硬化症中的皮肤特异性T细胞反应

2022-06-14

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

J Infect Dis:新冠病毒特异性T细胞在感染后12个月后仍然具有较高的表达

2022-06-26

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性

2021-08-27

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Science Immunol：COVID-19-急性呼吸窘迫综合征患者的SARS-CoV-2特异性T细胞的表型和动力学

2020-12-29

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Clin Cancer Res：CMV特异性T细胞治疗胶质母细胞瘤

2021-02-20

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Blood：SARS-CoV-2特异性T细胞可快速扩增以用于临床治疗

2021-02-01

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Nat Med：抗HIV-1抗体联合治疗与病毒特异性T细胞免疫力增强相关

2021-05-19

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

EBV特异性T细胞免疫疗法ATA188治疗多发性硬化症：所有剂量组均取得积极结果

2020-12-09

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关

2020-08-19

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Blood：在骨髓移植后，EBV/LMP特异性T细胞可有效维持EBV相关淋巴瘤的缓解

2019-04-07

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

CLIN CANCER RES：瘤内HPV16特异性T细胞可以改善HPV16导致的口咽癌预后

2019-01-15

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应

2018-05-03

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Blood：肿瘤特异性T细胞不能根除淋巴瘤起始B细胞！

2018-09-27

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

J Clin Invest：淋巴细胞短暂表达病毒特异性T细胞受体可减少乙型肝炎病毒感染

2018-06-28

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

JCO：病毒特异性T细胞可以抗病毒？

2018-03-31

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

J immunol：CD200R信号调节肿瘤特异性T细胞免疫反应

2016-07-14

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Clin Trans Immunol：PD-1抗体能够激活抗原特异性T细胞免疫反应

2016-12-27

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Nature ：同种异体IgG联合DC能强烈激活肿瘤特异性T细胞

2015-07-01

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

Science：ILC -III介导微生物特异性T细胞“阴性选择”

2015-07-27

zhucaizhong7774 (审核中...)

前往app查看评论内容

#特异性T细胞#

CELL STEM CELL：日培育出肿瘤抗原特异性T细胞

2013-07-12

科室
- - 订阅+
  - 更多科室
工具
服务